PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40126P00150 — CENTRAL NERVOUS SYSTEM (CNS)-3D BRAIN ORGANOIDS NEUROPHARMACOLOGICAL ANALYSIS EO 14398

CENTRAL NERVOUS SYSTEM (CNS)-3D BRAIN ORGANOIDS NEUROPHARMACOLOGICAL ANALYSIS EO 14398 is a federal NONE award for Department of Health and Human Services (HHS) held by 28BIO, INC.. Estimated value $143K ($143K obligated). Current period of performance ends Apr 30, 2027. Last award drew 1 bidder. Place of performance: METAIRIE LA. Related solicitation 75F40126Q134171.

$143K
Estimated Value
Apr 30, 2027
PoP End / Expires
1
Bidders (last award)
28BIO, INC.
Incumbent

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

28BIO, INC. holds $143K across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Apr 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75F40126P00150
AgencyDepartment of Health and Human Services (HHS)
Incumbent28BIO, INC.
CAGE75TQ1
UEIRT13MNMRHL33
NAICS541380

No full NAICS 541380 intel page yet. Browse NAICS intelligence

PSCB537
Place of performanceMETAIRIE LA
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
Related solicitation75F40126Q134171
PoP startAug 1, 2026
PoP end (current)Apr 30, 2027
Obligated$143K
Current value$143K
Potential value$143K

CENTRAL NERVOUS SYSTEM (CNS)-3D BRAIN ORGANOIDS NEUROPHARMACOLOGICAL ANALYSIS EO 14398

Recompete timing

Public
Expiring in 253 days

Current PoP ends Apr 30, 2027 (253 days remaining). Agencies typically plan 12–18 months ahead — at 8.3 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

28BIO, INC.$143K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$143K · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75F40126P00150
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open 28BIO, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75F40126P00150?

75F40126P00150 (CENTRAL NERVOUS SYSTEM (CNS)-3D BRAIN ORGANOIDS NEUROPHARMACOLOGICAL ANALYSIS EO 14398) is a Department of Health and Human Services (HHS) award with an estimated value of $143K, currently held by 28BIO, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75F40126P00150?

28BIO, INC. is the incumbent with $143K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Apr 30, 2027.

When does 75F40126P00150 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40126P00150

SCOUT Signal

August 2026

One VA health contract was 35% of civilian federal obligations in July.

Meanwhile VA's service-disabled veteran-owned contract actions fell 41.8%. The same agency, the same month, the large-vendor lane expanding while the small-business lane contracted. Figures are civilian-agency obligations through 2026-07-31; DoD FPDS for this window is labeled incomplete.

This issue is the whole civilian market. Your capture plan isn't.

Read the August 2026 issue →